Skip to content
Trial Eligibility
Menu

Adverse Outcomes and Mortality in Liver Transplant

NCT05477277

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • End Stage Liver DIsease
  • Sarcopenia
  • Sarcopenic Obesity
  • Cirrhosis

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Mayo Clinic
Last updated on ClinicalTrials.gov
August 5, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Arizona · 1

  • Mayo Clinic Arizona · Phoenix, AZ

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.